Top Markets
Coin of the day
Q BioMed Inc. Q BioMed Inc.

Q BioMed Inc.

QBIO
Rankning i aktier #41615
Q BioMed Inc. functions as a biomedical accelerator and developer, actively... Q BioMed Inc. functions as a biomedical accelerator and developer, actively licensing, acquiring, and supplying resources to firms within the life sciences and healthcare sectors. Its commercial portfolio includes Metastron (Strontium Chloride SR89), a radiopharmaceutical designed to alleviate pain associated with metastatic bone cancer. Additionally, Q BioMed is advancing a pipeline of therapeutic candidates, including Man-01, a pre-clinical compound aimed at primary open-angle glaucoma; QBM-001, intended for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, which targets liver cancer. The company also collaborates with Mannin Research Inc. on the development of treatments for conditions such as acute respiratory distress syndrome, glaucoma, and various kidney diseases. Incorporated in New York, New York, in 2013, the entity was initially named ISMO Tech Solutions, Inc. before adopting its current name, Q BioMed Inc., in July 2015.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-04-02
Marknadsvärde
$14.51K
Förändring (1 dag)
0.00%
Förändring (1 år)
9,900.00%
Land
US
Handel Q BioMed Inc. (QBIO)

Kategori

Historik för aktiesplit för Q BioMed Inc. (QBIO)
Aktien Q BioMed Inc. (symbol: QBIO) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 13, 2026.
En QBIO-aktie köpt före Aug 13, 2026 motsvarar nu 0 QBIO-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR